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Abstract
Background: Lentiviral vectors have been designed with complex RNA export sequences in both
the integrating and packaging plasmids in order to co-ordinate efficient vector production. Recent
studies have attempted to replace the existing complex rev/RRE system with a more simplistic
RNA export system from simple retroviruses to make these vectors in a rev-independent manner.
Results: Towards this end, lentiviral transfer plasmids were modified with various cis-acting DNA
elements that co-ordinate RNA export during viral production to determine their ability to affect
the efficiency of vector titer and transduction in different immortalized cell lines in vitro. It was
found that multiple copies of the constitutive transport element (CTE) originating from different
simian retroviruses, including simian retrovirus type 1 (SRV-1) and type-2 (SRV-2) and Mason-Pfizer
(MPV) could be used to eliminate the requirement for the rev responsive element (RRE) in the
transfer and packaging plasmids with titers >106 T.U./mL (n = 4–8 preparations). The addition of
multiple copies of the murine intracisternal type A particle, the woodchuck post-regulatory
element (WPRE), or single and dual copies of the simian CTE had minimal effect on viral titer.
Immortalized cell lines from different species were found to be readily transduced by VSV-G
pseudotyped lentiviral vectors containing the multiple copies of the CTE similar to the findings in
HeLa cells, although the simian-derived CTE were found to have a lower infectivity into murine cell
lines compared to the other species.
Conclusion:  These studies demonstrated that the rev-responsive element (RRE) could be
replaced with other constitutive transport elements to produce equivalent titers using lentivectors
containing the RRE sequence in vitro, but that concatemerization of the CTE or the close proximity
of RNA export sequences was needed to enhance vector production.
Background
Gene transfer applications have been widely developed
over the past decade using various viral and non-viral vec-
tors, including lentivectors based on the human immun-
odeficiency virus [1]. Significant modifications have been
made in the HIV-based vectors since the initial findings by
Naldini et al. [2] that have allowed the vector to perform
effectively in the absence 5 out of the 9 wild-type HIV
genes, specifically vif, vpr, vpu, nef and tat [3-7]. Continual
efforts in the past few years have attempted to further
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delete wild-type HIV sequences in the lentiviral transfer
(integrating) and packaging vector to enhance vector titer
and transgene expression. One of the main regulatory
genes, rev, has remained in many of the advanced lentivec-
tors, and this protein is known to bind to its cis-acting
DNA element, rev-responsive element (RRE). This rev/
RRE system is important to the efficient transport of
unspliced viral RNA genomes from the nucleus into the
cytoplasm to properly assemble the lentivector particles
[8]. There has been recent work to assess the use of alter-
native RNA export sequences from simple retroviruses to
replace the more complex rev/RRE system, including indi-
vidual copies of simian retrovirus [9,10] and Mazon-
Pfizer [11,12] constitutive transport element (CTE). The
results in terms of viral titer varied from extremely poor
[11,12] to moderately high [9]. Moreover, the previous
studies produced the vector using RRE-dependent packag-
ing systems. Earlier work by Wodrich et al. [13] demon-
strated that gag  polyprotein (Pr55) expression can be
significantly elevated if multiple copies of the Mason-
Pfizer CTE were incorporated into the gag-pol expression
plasmid compared to a single copy of the CTE, which may
circumvent the requirement of the rev/RRE post-transcrip-
tional control systems in vector production.
At present, there have been no attempts to produce lenti-
viral vectors with multiple copies of CTE in either the
transfer (integrating) or packaging plasmids. For this rea-
son, the goal of the present study was to develop alterna-
tive versions of lentivectors using concatemer RNA export
sequences from simple retroviruses to determine the dis-
pensability of the complex rev/RRE system to generate
high-titer lentiviral vectors. In our study, we compared the
role of the woodchuck post-regulatory element (WPRE) as
well as the efficacy of various constitutive transport ele-
ments (CTE) from simian retrovirus type 1 (SRV-1) and
type-2 (SRV-2), Mason-Pfizer retrovirus, and the murine
intracisternal type A particle element (IAPE). In all, these
basic vector issues should help to better understand the
role of RNA export sequences in the effective production
of lentiviral vectors and their functionality in vitro.
Results
Construction of advanced lentivector transfer plasmids 
using different cis-acting DNA elements
As shown in Figure 1, lentivector transfer plasmids were
cloned with a variety of RNA export/transport elements to
determine their ability to generate lentivectors titers
equivalent to the existing rev/RRE system.
The basic lentivector transfer plasmid used in this study
contained the phosphoglycerokinase (PGK) promoter
driving the expression of nuclear localized bacterial lacZ
gene. In addition, the cis-acting DNA element known as
the central polypurine tract sequence (or cppt) from the
pol gene was included 5' to the PGK promoter due to its
well-known ability to enhance viral transduction effi-
ciency [4-6]. Splice donor (SD) and acceptor (SA) sites
were included in every transfer vector plasmid. The viral
titer of this basic lentivector was 9.9 +/- 1.0 × 103 T.U./mL.
The WPRE did not significantly enhance the viral titer
(30.8 +/- 8 × 103 T.U./mL; n = 4), which was expected
since its main functional role is to stabilize expressed tran-
scripts [14]. The insertion of the RRE into the transfer plas-
mid 5' to the PGK promoter [pHRSVR(+)cPGKnlsLacZR(-
)W(-)] increased the viral titer to 50.4 +/- 3.5 × 103 T.U./
mL (n = 5), and there appeared to be a co-operative effect
on viral titer when the RRE was included into the lentivec-
tor transfer plasmid 5' to the PGK promoter with the
WPRE near the 3' self-inactivating long-terminal repeat
(SIN LTR; 109 +/- 14 × 103 T.U./mL; n = 4). The incorpo-
ration of the RRE into our lentivector transfer plasmid was
position-dependent, since we found that the placement of
the RRE near the 3' end of the lentivector resulted in a sig-
nificant enhancement of viral titer to 1,080 +/- 84 × 103
T.U./mL, which was ~20-fold higher than the RRE
sequence in the 5' region of the vector.
To determine whether RNA export sequences from other
simple retroviruses could replace the RRE to maximize
lentivector titer, we cloned four different constitutive
transport elements (CTEs) from simian retrovirus type 1
(SRV-1) and 2 (SRV-2), Mazon-Pfizer retrovirus (MPV),
and murine intracisternal A-type particles (IAP). A single
copy insertion of a minimal CTE from SRV-1 near the 3'
SIN LTR of the lentivector transfer plasmid resulted in no
detectable change in viral titer (11 +/- 3 × 103 T.U./mL)
compared to the lentivector transfer plasmid, pHRSVcPG-
KnlsLacZR(-)W(-). Incorporation of a second CTE
resulted in a slight increase in the lentivector titer to 47 +/
- 8 × 103 T.U./mL (n = 3). A position-effect was observed
if the dual CTE complex was cloned into the 5' end of the
lentivector transfer plasmid adjacent to the gag gene frag-
ment, since the titer increased by ~2-fold to 98 +/- 16 ×
103 T.U./mL (n = 4).
As we increased the number of SRV-1 CTE to 4 head-to-tail
copies, we calculated a significant increase (p < 0.05) in
viral titer to 1,130 +/- 90 × 103 T.U./mL (n = 8). The
increase in viral titer with the four copies of the SRV1 CTE
was ~3-log orders higher than the vectors containing only
one copy of the SRV-1 CTE. Comparatively, lentivector tit-
ers were observed to be in the 106 T.U. range even with the
replacement of the SRV-1 CTEs with either SRV-2 or MPV
CTE, i.e., 1,230 +/- 90 × 103 T.U./mL (n = 5) and 1,614 +/
- 237 × 103 T.U./mL (n = 5), respectively.
Insertion of the WPRE 3' to the 4 multimeric copies of the
SRV-1 did not result in a marked change in the viral titer.
Since the WPRE is known to enhance the stability ofRetrovirology 2007, 4:38 http://www.retrovirology.com/content/4/1/38
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Schematic of a panel of transfer plasmids containing different cis-acting DNA elements: Role on viral titer and transduction effi- ciency Figure 1
Schematic of a panel of transfer plasmids containing different cis-acting DNA elements: Role on viral titer and 
transduction efficiency. The basic lentiviral transfer plasmid used in this experiment were derivatives of the pHRSVcPG-
KnlsLacZR(-)W(-), which contains the murine PGK promoter driving the expression of the nuclear localized lacZ gene 
(nlsLacZ). The central polypurine tract sequence (cppt; GREY box) was cloned into all of the lentiviral transfer plasmids to 
maximize transduction efficiency. Splice donor (SD and acceptor (SA) sites were included in every transfer plasmid. Viral titer 
was determined by end-point dilution on HeLa cells, and p24 Gag protein levels were determined by ELISA. C = constitutive 
transport element; WPRE = woodchuck post-regulatory element; RRE = rev-responsive element; SIN LTR = 3' self-inactivating 
long-terminal repeat. n = 4–8 different lentiviral preparations/transfer plasmid. * p < 0.05 difference between the basic lentiviral 
vector (pHRSVcPGKnlsLacZR(-)W(-).
Transduction Efficiency
(T.U./ng p24)
pHRSVR(+)cPGKnlsLacZR(-)W(+)
PRE
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
RRE PGK
pHRSVcPGKnlsLacZR(+)W(+)
PRE
SIN LTR
gag
SA SDψ ψ ψ ψ 5’LTR
RRE PGK nls LacZ
gag
SA SDψ ψ ψ ψ 5’LTR SIN LTR
PGK nls LacZ
pHRSVcPGKnlsLacZR(-)W(-)
40,276 +/- 3,185 (n=5)*
291 +/- 16 (n=5)
2,435 +/- 191 (n=4)
Viral Titer
(x 103 T.U./mL)
9.9 +/- 1.0 (n=5) 
5’LTR
gag
SA SDψ ψ ψ ψ SIN LTR
RRE PGK nls LacZ
pHRSVR(+)cPGKnlsLacZR(-)W(-)
2,007 +/- 973  (n=7) 50.4 +/- 3.5 (n=7)
pHRSVRcPGKnlsLacZR(-)W(+)
PRE
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
PGK 663 +/- 76 (n=5) 30.8 +/- 8 (n=5)
1,080 +/- 84 (n=5)*
109 +/- 14 (n=4)
Transfer plasmid
pHRSVcPGKnlsLacZS1.1(+)
C
SIN LTR
gag nls LacZ
5’LTR
PGK
pHRSVcPGKnlsLacZS1.4(+)
C
SIN LTR
gag nls LacZ
5’LTR
PGK C CC 6,684 +/- 542 (n=5)*
314 +/- 8 (n=5)
pHRSVcPGKnlsLacZS1.4(+)W(+)
C
SIN LTR
gag nls LacZ
5’LTR
PGK CC C PRE 4,703 +/- 1,727 (n=5)
21 +/- 0.7 (n=5)
1,130 +/- 90 (n=8)*
20 +/- 10 (n=4)
1,214 +/- 890 (n=5)*
pHRSVcPGKnlsLacZS2.4(+)
C
SIN LTR
gag nls LacZ
5’LTR
PGK C C C
1,750 +/- 254 (n=5) 1,230 +/- 90 (n=5)*
10 +/- 1 (n=5)
pHRSVcPGKnlsLacZM4(+)
C
SIN LTR
gag nls LacZ
5’LTR
PGK C C C
2,294 +/- 392 (n=5) 1,614 +/- 237 (n=5)*
8 +/- 8 (n=5)
+ rev
-r e v
+ rev
-r e v
+ rev
-r e v
pHRSVcPGKnlsLacZS1.2(+)
C
SIN LTR
gag nls LacZ
5’LTR
PGK C 47 +/- 8.0 (n=4)
pHRSVS1.2(+)cPGKnlsLacZ
C
SIN LTR
gag nls LacZ
5’LTR
PGK C 98 +/- 16 (n=4)
not determined
not determined
pHRSVcPGKnlsLacZI.1(+)
I
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
PGK 6 +/- 1.4 (n=5)
pHRSVcPGKnlsLacZI.3(+)
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
PGK 10 +/- 1.6 (n=5) I I I
not determined
not determined
pHRSVcPGKnlsLacZRTE.CTE(+)
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
PGK 768 +/- 111 (n=4)* R C not determined
SA SDψ ψ ψ ψ
SA SDψ ψ ψ ψ
SA SDψ ψ ψ ψ
SA SDψ ψ ψ ψ
SA SDψ ψ ψ ψ
SA SDψ ψ ψ ψ
SA SDψ ψ ψ ψRetrovirology 2007, 4:38 http://www.retrovirology.com/content/4/1/38
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mRNA transcripts [14], we examined whether the incor-
poration of the WPRE in combination with the mul-
timeric CTE would affect the steady-state protein levels
following transduction (Figure 2). Total β-gal protein lev-
els following the transduction of MDCK cells (at a MOI 3)
using the pHRSVcPGKnlsLacZS1.4(+)W(+) transfer vector
resulted in an increase of 6.5-fold compared to the
pHRSVcPGKnlsLacZS1.4(+) transfer vector (i.e., 24,990
+/- 8,134 versus 3,611 +/- 778 pg β-gal/mg protein). Sim-
ilar increases in β-gal protein levels were found in RAG
cells using a MOI 1 (6,002 +/- 2,721 versus 932 +/- 185 pg
β-gal/mg protein; n = 5). These results demonstrated that
the WPRE in the context of bacterial lacZ gene could
enhance the level of transgene expression, which is similar
to previous studies in our lab using second-generation
lentivector systems [15].
Role of the murine intracisternal type A element (IAPE) on 
viral titer
A CTE-related element known as a RNA transport element
(RTE), which is located within an introns of the osteocal-
cin-related gene, and previously found to functionally
replace the rev/RRE during HIV replication [16], was
cloned in close proximity to the minimal SRV-1 CTE and
found to significantly increase the viral vector titer to 768
+/- 111 × 103 T.U./mL compared to the SRV-1 CTE alone
(11 +/- 3 × 103 T.U./mL).
Another murine IAP element (IAPE), which was located in
the pol gene of MIA14 [17], was cloned into the lentivector
transfer plasmid resulting in no significant change in
functional titer (6.0 +/- 1.4 × 103 T.U./mL) compared to
the RNA export minus lentivector system (9.9 +/- 1.0 ×
103  T.U./mL). Inserting two additional copies of the
murine IAPE only increased the viral titer to 1.0 +/- 1.63 ×
104 T.U./mL, and this appeared to be orientation-depend-
ent since the IAPE inserted into the opposite direction
resulted in no detectable X-gal positive HeLa cells (data
not shown). There would appear to be a variable effect by
different IAPE on their functional ability to replace the
rev/RRE system to generate lentiviral vector stocks.
Lentivector transduction into immortalized kidney cell 
lines from different species
The optimal lentivectors as determined in HeLa cells were
used to transduce a variety of kidney-derived cell lines in
vitro. As shown in Figure 3, the lentivectors that contained
the RRE in the 3' end were found to transduce 1.08 +/-
0.08 × 106 T.U./mL in HeLa cells. It was found that all of
the immortalized cell lines from a number of different
species were not as efficient on viral uptake, integration,
and expression of the lacZ gene using the VSV-G pseudo-
typed advanced lentivectors. All of the cells lines derived
from dogs (MDCK), monkeys (COS-7), and mice (TCMK-
1 and RAG) had similar levels of transduction with the
highest transduction found in the RAG cell line (2.52 +/-
0.28 × 105 T.U./mL).
On the other hand, lentivectors containing multiple cop-
ies of the CTE (see Figure 3B) in the transfer plasmid trans-
duced COS-7 and MDCK at similar efficiencies as the
lentivectors containing the RRE. However, there was a sig-
nificantly lower lentivector titer in the murine cell lines
(TCMK-1 and RAG). Similar results were obtained using
lentivectors containing the multimer copies of the MPV
CTE (Fig. 3C). One of the main reasons for the lower viral
titer on the murine cell lines, particularly TCMK-1, may be
due to the origin of the CTE, which is simian in nature,
and so cell lines derived from large animal species may
have cellular factor(s) that are not normally present in
rodents.
Role of the WPRE on β-gal protein expression in cell lines  following lentiviral vector transduction Figure 2
Role of the WPRE on β-gal protein expression in cell 
lines following lentiviral vector transduction. Canine 
(MDCK; Fig. 2A) and murine (RAG; Fig. 2B) immortalized 
cells were transduced with lentiviral vectors in the presence 
and absence of the WPRE in the transfer plasmid. The lentivi-
ral transfer plasmid used in this experiment was the 
pHRSVcPGKnlsLacZS1.4(+) and 
pHRSVcPGKnlsLacZS1.4(+)W(+). The MDCK (MOI 3) and 
RAG (MOI 1) were transduced with the VSV-G pseudotyped 
lentiviral vectors and 48 hours later, the proteins were iso-
lated and assayed for β-gal protein by ELISA. C = central 
polypurine tract sequence; PGK = murine phosphoglyceroki-
nase promoter; nlsLacZ = nuclear localized lacZ gene; 
S1.4(+) = 4 copies of the SRV-1 CTE; W(-) = no WPRE; 
W(+) = WPRE. n = 3–5 different samples/lentiviral prepara-
tion. * p < 0.01 difference between the different groups.
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Construction of different lentivector packaging plasmids
Minimal packaging plasmids containing the gag-pol genes
from HIV-1 were cloned as described in the Materials and
Methods, in which the DNA sequences attributed to the
expression of the viral accessory genes were deleted. As
shown in Figure 4, there did not appear to be any signifi-
cant difference in viral titer using different cis-acting DNA
elements in the packaging constructs. Various transfer
plasmids were examined to determine their compatibility
with different packaging plasmid containing the RRE or
multiple sequences of the SRV-1 CTE. Our study found
that there was a marked difference in p24 Gag protein lev-
els depending on the combination of transfer and packag-
ing plasmid used for lentivector production as the levels
ranged from 47 +/- 5 ng/mL (n = 5;
pCMV.gag.pol.RRE.bpA) to 858 +/- 109 ng/mL [n = 5;
pCMV.gag.pol.C4(+).bpA]. p24 Gag protein measure-
ments by ELISA has been one common method to titer
lentivector preparations, and generally, the functional
viral titer of lentiviral vectors is dependent upon the p24
Gag protein levels. For this reason, we cloned the consen-
sus Kozak sequence (CCACCATGG) in front of the Gag-
pol genes in the packaging construct to enhance transla-
tion of p24 Gag protein production. As shown in Figure
4A, the viral titer in HeLa cells were similar (between 2–4
× 106 T.U./mL) following the production of a lentiviral
vector containing the same transfer plasmid, but using
two different gag-pol constructs to express the structural
and packaging genes. The interesting finding was that
inclusion of the Kozak sequence
(pCMV.Kozak.gag.pol.RRE.bpA) resulted in an approxi-
mate 3-fold increase of p24 Gag protein to 147 +/- 12.5
ng/mL, but the functional viral titer as determined by end-
point dilution did not markedly change compared to the
packaging plasmid without the Kozak sequence. Interest-
ingly, the p24 Gag levels were 2–3-fold higher using a
transfer plasmid containing multiple CTE elements with
either a RRE-containing packaging plasmid or a WPRE-
containing packaging plasmid. The elevated p24 Gag pro-
tein levels did not appear to affect the viral titers in a pos-
itive way. These results demonstrate that the functional
titer is not necessarily a function of the p24 Gag protein
levels provided that a minimal threshold of gag protein is
produced, and that several different factors, such as opti-
mizing translation start site and other cis-acting DNA ele-
ments may play a role in producing high titer vector.
Another interesting aspect from our experiments was the
RRE-dependent increase in vector titer even in the absence
of the RRE in both the transfer and packaging plasmids.
The co-transfection of the rev-expressing plasmid during
vector production resulted in a consistent increase in viral
titer by 2–5 fold depending on the transfer plasmid used
in these studies (Figure 4B and 4C). There was definite rev-
dependence in producing even moderate levels of func-
tional lentiviral vector when the RRE was cloned within
the packaging plasmid (Figure 1). There was no difference
in the rev-dependence on increasing viral titer regardless
of the source of the CTE (i.e., MPV or SRV-1), but the main
issue is that vector titer using packaging plasmids with
multiple copies of the CTE replacing the RRE could pro-
duce relatively high titer vector, but that the expression of
rev would further increase the viral titer. The mechanism
is not known, but it could be due to the significant sec-
In vitro analysis of viral transduction into a panel of immortal- ized cell lines Figure 3
In vitro analysis of viral transduction into a panel of 
immortalized cell lines. Advanced lentiviral vectors were 
used for transduction into various immortalized kidney-based 
cell lines. COS-7 (African green monkey), MDCK (dog), 
TCMK-1 and RAG (mouse) were transduced with VSV-G 
pseudotyped lentiviral vectors produced in 293T cells using 
three different transfer plasmids, pHRSVcPG-
KnlsLacZR(+)W(+) (Fig. 3A), pHRSVcPGKnlsLacZS1.4(+) 
(Fig. 3B) and pHRSVcPGKnlsLacZM4(+) (Fig. 3C). n = 5 dif-
ferent lentiviral preparations/cell line. * p < 0.05 difference 
between HeLa versus all of the other immortalized cell lines.
Viral Titer
(TU/mL)
COS-7 MDCK  RAG TCMK-1  HeLa 
pHRSVcPGKNLSLacZR(+)W(+)
103
104
105
106
107
*
A.
103
104
105
106
107
pHRSVcPGKNLSLacZS1.4(+)
COS-7 MDCK RAG TCMK-1  HeLa 
*
B.
Viral Titer
(TU/mL)
MDCK RAG TCMK-1  HeLa 
Viral Titer
(TU/mL)
103
104
105
106
107
pHRSVcPGKNLSLacZM4(+) *
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ondary structure that could form using the multimeric
CTE, which could simulate the secondary structure of the
RRE, or that rev protein indiscriminately binds to second-
ary structures or DNA elements in the vector to allow for
efficient export of the unspliced gene products and viral
genomes into the cytoplasmid for assembly.
Discussion
The present study demonstrated the importance of multi-
ple RNA export sequences to replace the rev/RRE system in
the production of replication-defective lentiviral vectors.
The incorporation of alternative RNA export elements
into the packaging plasmid would potentially eliminate
the need for the expression of the rev gene during vector
production. RNA export sequences, such as constitutive
transport elements (CTE), are known to increase the via-
bility of the RNA genome of simple and complex retrovi-
ruses by transporting unspliced genomic RNA from the
nucleus to the cytoplasm for packaging and assembly into
viral particles. For this reason, the incorporation of alter-
native RNA export elements into the packaging plasmid
would potentially eliminate the need for the expression of
the rev gene during vector production.
In our present study, however, we demonstrated that min-
imal lentivectors could be designed in which the RRE was
replaced in both the transfer or packaging plasmid
through the incorporation of multiple copies of different
RNA export sequences, specifically the CTE from SRV-1,
SRV-2 or MPV. Each of the concatemeric CTE sequences in
the context of the lentiviral transfer vector resulted in rel-
atively high viral titers (>106 T.U./mL) compared to lenti-
viral vectors containing individual copies of the CTE.
Other cis-acting elements, such as the woodchuck post-
regulatory element (WPRE), did not play a significant role
in enhancing viral titer, but may have been involved in
transcript stability [14] and/or transgene expression
[15,18].
Consistent with previous studies using simple [18] and
complex retroviral vectors [11,12], an individual copy of
the CTE was unable to replace the RRE in enhancing the
production of functional vector particles. There have been
previous reports documenting the detection of functional
lentivector titers [9,19] and HIV-1 replication [10,17,20]
using individual copies of SRV-1 [9,10] and murine IAP
[17,20] using a rev-dependent system. In these studies, the
lentivector titers [9,19] and HIV-1 replication [10,20]
were ~20- and ~10-fold lower, respectively, using the CTE
compared to the RRE.
Early efforts to develop a complete rev-independent HIV-
1 based vector system was achieved by Kotsopoulou et al.
[21] who codon-optimized the gag-pol genes to minimize
the genetic overlap between the transfer and packaging
plasmids during vector production. However, the codon-
optimized lentivector appeared to be dependent on the
presence of rev, since viral titers would drop 20-fold in the
absence of the rev protein. Coincidentally, the lentivector
titers in the absence of rev (3–4 × 105 T.U.mL) in the Kot-
sopoulou et al. [21] study were similar to the titers in our
Schematic and viral titer of different lentiviral vector packag- ing constructs Figure 4
Schematic and viral titer of different lentiviral vector 
packaging constructs. Lentiviral vectors were produced 
using different transfer plasmids containing RRE (Fig. 4A) or 
multiple copies of SRV-1 (Fig. 4B) or MPV CTE (Fig. 4C). 
Viral titer was determined by end-point dilution using X-gal 
stained HeLa cells and p24 Gag protein ELISA. HATCHED 
bars = Kozak sequence (CCACCATGG); W = woodchuck 
post-regulatory element; C = constitutive transport element; 
pA = bovine growth hormone poly(A) signal; RRE = rev-
responsive element; SD = splice donor; SA = splice acceptor. 
* p < 0.05 difference between lentiviral vectors produced 
with or without the rev protein.
pHRSVcPGKnlsLacZR(+)W(+)
PRE
SIN LTR
gag
SA SDψ ψ ψ ψ 5’LTR
RRE PGK nls LacZ Transfer plasmid:
A.
pHRSVcPGKnlsLacZS1.4(+)
C
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
PGK CCC Transfer plasmid:
B.
pCMV.gag.pol.RRE.bpA
+ rev 23.2 +/- 3.9 (n=5)
Viral titer
(x 105 T.U./mL)
344 +/- 45
p24 Gag
(ng/mL)
pCMV.gag.pol.C4(+).bpA
pCMV.gag.pol.C4(+)W(+).bpA
12.6 +/- 0.9 (n=5)
3.3 +/- 0.7 (n=5)*
20.2 +/- 2.3 (n=5)
4.0 +/- 1.9 (n=5)*
+ rev
-r e v
577 +/- 57
566 +/- 34
404 +/- 34
208 +/- 25
+ rev
-r e v
CMV pol C pA C C C gag W
CMV pol C pA C C C gag
CMV pol RRE pA gag
pCMV.gag.pol.RRE.bpA
+ rev 20.6 +/- 3.0 (n=5)
Viral titer
(x 105 T.U./mL)
47 +/- 5
p24 Gag
(ng/mL)
pCMV.kozak.gag.pol.RRE.bpA
29.2 +/- 2.8 (n=5) 147 +/- 13 + rev
CMV pol RRE pA gag
CMV pol RRE pA gag
pHRSVcPGKnlsLacZM4(+)
C
SIN LTR
gag nls LacZ
SA SDψ ψ ψ ψ 5’LTR
PGK CCC
pCMV.gag.pol.C4(+).bpA
18.5 +/- 1.7 (n=5)
9.9 +/- 1.2 (n=5)*
858 +/- 109
776 +/- 32
+ Rev
-R e v
Transfer plasmid:
Viral titer
(x 105 T.U./mL)
p24 Gag
(ng/mL)
C.
CMV pol C pA C C C gagRetrovirology 2007, 4:38 http://www.retrovirology.com/content/4/1/38
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present study without rev (i.e., our newly developed three-
plasmid system) using the multimeric SRV-1 CTE-con-
taining transfer constructs. In our study, we were capable
of generating lentiviral titers in excess of 106 T.U./mL in a
rev-independent manner using multiple copies of the
MPV CTE. Although the mechanism by which the mul-
timeric copies of the CTE produced higher vector titers
were not determined in our study, it is likely that there was
more efficient export of the unspliced viral RNA genome
from the nuclei to the cytoplasm allowing for more effec-
tive packaging during assembly into a functional vector,
which would be consistent with a previous study by
Wodrich et al. [13].
Other RNA export sequences from murine origin known
as intracisternal A-type particles (IAP) were examined for
their function on viral titer. In our hands, we found that
the insertion of a single RNA export element from IAP
(IAPE) did not affect the viral titer even if multiple copies
were included into the transfer plasmid. This contrasts
with the previous studies by Wodrich et al. [17], who
showed that the IAPE could significantly enhance Gag
protein expression in a rev-independent manner, but
apparently in the context of generating functional len-
tivector particles, the IAPE is incapable of sufficiently
replacing the rev/RRE nor the CTE systems. On the other
hand, a distinct murine IAP known as the RTE cloned in
close proximity of an individual SRV-1 CTE has been
shown to replace the rev/RRE system during HIV replica-
tion [22,23]. Consistent with these previous findings, we
found that the RTE-CTE complex increased the lentiviral
vector titer by ~37-fold compared to the lentiviral vector
with only a single copy of the SRV-1 CTE (Figure 1). Inter-
estingly, the incorporation of the RTE 5' to 4 copies of the
MPV CTE (data not shown) did not affect the viral titer,
which may be due to the saturation of the RNA export sys-
tem resulting in a maximal amount of unspliced RNA for
viral packaging and protein translation.
One important caveat to the replacement of the regulated
rev/RRE system with multiple copies of the RNA export
elements from simple retroviruses is the potential for
intermolecular recombination during vector production
due to the extremely high nucleotide homology of these
elements (88–92% identical). Therefore, the use of differ-
ent CTEs may not make a significant difference in mini-
mizing recombination. However, we have performed
replication-competency assays to measure for p24 Gag
antigen by ELISA and have not seen any difference in RCL
formation regardless of the combination of CTE elements
compared to the widely used RRE-containing vector sys-
tems (data not shown), but more sensitive PCR based
assays may discover intermolecular recombination at the
genetic level.
Conclusion
Our present study demonstrated that advanced lentivec-
tors can be effectively produced using alternative RNA
export sequences from simple retroviruses at fairly high
titers (>106 T.U./mL) provided that they are incorporated
as a concatemer or in close proximity with one another.
These experiments define the importance of certain cis-
acting DNA elements in the context of lentiviral vector
production.
Methods
Construction of the 5' long terminal repeat (LTR) fused 
with the Rous Sarcoma Virus U5 region
The RSV U5 region was amplified from pRSV.hAAT.bpA
(Yant et al., 2000; generously given to me by Dr. Stephen.
R. Yant, Stanford, CA) and ligated into the SmaI site of
pBS.HIVLTR to make pRSV.HIVLTR. The SV40 poly(A)
signal was amplified by PCR and cloned into the novel
PmeI site 5' to the RSV U5 region in pRSV.HIVLTR to make
pSV40pA.RSV.HIVLTR, which was subsequently cloned
into a lentiviral vector transfer plasmid through multiple
standard cloning steps.
Construction of transfer plasmids containing different cis-
acting DNA elements
The basic lentiviral transfer plasmid, pHRSVcPG-
KnlsLacZR(-)W(-) contained the murine phosphoglycer-
okinase (mPGK) promoter driving the expression of the
nuclear localized lacZ gene. The central polypurine tract
sequence (cppt; Zennou et al., 2000) was cloned 5' to the
mPGK promoter into the XhoI site. pHRSVcPG-
KnlsLacZR(-)W(+) was cloned by replacing the NdeI/NheI
site from pHR'CMVlacZW(+)SIN into the NdeI/NheI site
of pHRSVcPGKnlsLacZR(-)W(-). The pHRSVR(+)cPG-
KnlsLacZR(-)W(-) and pHRSVR(+)cPGKnlsLacZR(-)W(+)
plasmids were cloned by inserting the NotI/XhoI fragment
from pHR(+)cPGKnlsLacZR(-)W(+) into the NotI/XhoI
site of pHRSVcPGKnlsLacZR(-)W(-) and pHRSVR(+)cPG-
KnlsLacZR(-)W(+), respectively. The pHRSVcPG-
KnlsLacZR(+)W(+) plasmid was produced by inserting
the  NdeI/NheI fragment from pHR(-)cCMVsol-
lacZR(+)W(+) into pHRSVcPGKnlsLacZR(-)W(-).
Construction of SRV-1 CTE-containing shuttle plasmids
Minimal 173 bp SRV-1 CTE was PCR amplified from
pNL43R(-)Rev(-).S (generous gift from Dr. Barbara K. Fel-
ber, NCI-FCRDC, Frederick, Md) and cloned into the
BamHI site of pBS.bpA, which contained the bovine
growth hormone poly(A) signal, to make pBS.CTE.bpA.
Additional copies of the CTE (BamHI/BglII fragment)
were cloned into the BamHI site to make pBS.CTE4.bpA.
The WPRE was amplified from pBS.SK(+).WPRE.B11
(generously given to us by Thomas J. Hope, Univ. of Illi-
nois, Champaign, Il) and cloned into the pBS.CTE4.bpA
plasmid to make pBS.C4(+)W(+).bpA.Retrovirology 2007, 4:38 http://www.retrovirology.com/content/4/1/38
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Construction of SRV-1 CTE-containing transfer plasmids
pHRSVcPGKnlsLacZR(-)W(-) was digested to insert the
CTE from pBS.CTE in order to make
pHRSVcPGKnlsLacZS1.1(+). To make
pHRSVcPGKnlsLacZS1.4(+), the pBS.C4(+) plasmid was
digested with BamHI and KpnI and inserted into pHRS-
VcPGKnlsLacZR(-)W(-). The C4(+)W(+) fragment was
cloned into the pHRSVcPGKnlsLacZR(-)W(-) to make
pHRSVcPGKnlsLacZS1.4(+)W(+).
Construction of SRV-2 CTE-containing transfer plasmids
Minimal 173 bp SRV-2 CTE was PCR amplified (generous
gift from Dr. Barbara K. Felber, NCI-FCRDC, Frederick,
Md) and cloned into the BamHI site of pBS.bpA, which
contained the bovine growth hormone poly(A) signal, to
make pBS.S2.1(+).bpA. Additional copies of the SRV-2
CTE (BamHI/BglII fragment) were cloned into the BamHI
site to make pBS.S2.4(+).bpA. To make
pHRSVcPGKnlsLacZS2.4(+), the pBS.S2.4(+) plasmid was
blunt digested, gel purified, and cloned into the PmeI site
of pHRSVcPGKnlsLacZPmeI.
Construction of MPV CTE-containing transfer plasmids
Minimal 174 bp MPV CTE was PCR amplified (generous
gift from Dr. Barbara K. Felber, NCI-FCRDC, Frederick,
Md) and cloned into the BamHI site of pBS.bpA, which
contained the bovine growth hormone poly(A) signal, to
make pBS.M1(+).bpA. Additional copies of the MPV CTE
(BamHI/BglII fragment) were cloned into the BamHI site
to make pBS.M4(+).bpA. To make
pHRSVcPGKnlsLacZM4(+), the pBS.M4(+).bpA plasmid
was digested with BamHI and KpnI and inserted into
pHRSVcPGKnlsLacZR(-)W(-).
Construction of IAPE-containing transfer plasmids
pHR'CMVlacZSIN-18F was digested with KpnI, blunted
with Klenow fragment, and the minimal IAPE (isolated
from 3-IAPE plasmid by PCR amplification; generous gift
from Dr. H. Wodrich, Salk Institute, La Jolla, CA) was
inserted to make pHR'CMVlacZI(+). This plasmid was
subsequently digested with NdeI/NheI and the fragment
containing the IAPE and 3' SIN LTR was cloned into
pHRSVcPGKnlsLacZR(-)W(+) to make pHRSVcPG-
KnlsLacZI(+). Three copies of the IAPE were cloned into
pBS-SK(-).IAPE3, and then digested with PmeI/SmaI for
insertion into the novel PmeI site in pHR'CMVlacZ PmeI-
SIN to make pHR'CMVlacZI.3(+). Note that the IAPE3
was cloned in both the forward and reverse directions.
This was subsequently cloned into pHRSVcPG-
KnlsLacZR(-)W(+) and the R(+)W(+) segment was
replaced to make pHRSVcPGKnlsLacZI.3(+) in the sense
and antisense directions.
Construction of RTEm26-CTE-containing transfer 
plasmids
pHRSVcPGKnlsLacZPmeISIN was digested with PmeI,
which was a novel site near the 3' SIN LTR. The
pNLgagM26CTE (generous gift from Dr. B. K. Felber) was
double digested with KpnI/SalI and blunted with T4 DNA
polymerase for ligation into the PmeI site. The final con-
struct was pHRSVcPGKnlsLacZRTEm26CTE(+). Another
construct was cloned to replace the single copy of the SRV-
1 CTE with a multimer of CTE (4 copies) from the MMPV
CTE to make the final construct of
pHRSVcPGKnlsLacZRTEM4(+).
Construction of the packaging plasmid
pCMV∆R8.74 [3] was digested with XbaI and EcoRI, and
an oligo linker containing novel BamHI and PmeI sites
was inserted into the packaging plasmid backbone. The
BamHI/PmeI fragment from pBS.RRE.bpA was inserted
into pCMV.gag.pol.oligo to make
pCMV.gag.pol.RRE.bpA. The pBS.C4(+).bpA plasmid was
digested with BamHI and PmeI, and this fragment was
inserted into pCMV.gag.pol.oligo to make
pCMV.gag.pol.C4(+).bpA. The packaging plasmid,
pCMV.gag.pol.C4(+)W(+).bpA was made by inserting the
C4(+)W(+)bpA fragment into the BamHI/PmeI sites.
PCR assay
Oligonucleotides were purchased from Integrated DNA
Technologies (Coralville, IA). All PCR conditions were
similar and used the following conditions: 3' at 94°C (ini-
tial melt) followed by 35 cycles of 94°C for 30 sec, 55°C
for 30 sec, and 72°C for 10 sec. Final extension was per-
formed at 72°C for 7 minutes. All sequences that were
amplified and cloned into the vectors were sequenced.
Cell lines
Kidney-derived cells lines from different species were
obtained from ATCC, specifically LLC-PK1  (porcine),
MDCK (canine), TCMK-1 (mouse), RAG (mouse) and
293T cells (human). COS-7 cells (African green monkey)
were obtained from Dr. S. M. Lanier (Medical University
of South Carolina, Charleston, SC).
Envelope pseudotype plasmids
pMD.G is the envelope plasmid and encodes the vesicular
stomatitis virus G protein as previously described [3].
Lentiviral vector production
Modified second-generation lentiviral vectors were pro-
duced by transient triple-plasmid transfection of 293T
cells as previously described [5,24,25]. The advanced
third-generation lentiviral vectors were produced by a
similar manner as the three-plasmid system, but the fol-
lowing amounts of plasmid DNA were used: 10 µg trans-
fer plasmid, 6.5 µg packaging plasmid, 3.5 µg envelopeRetrovirology 2007, 4:38 http://www.retrovirology.com/content/4/1/38
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plasmid and 5 µg rev-expressing plasmid (pRSV121; gen-
erous gift from Dr. T. J. Hope, University of Illinois). Con-
ditioned media were collected at 48 hrs, filtered and
frozen at -80°C. End-point dilution by X-gal staining was
performed on HeLa cells when titering lacZ-expressing
lentiviral vectors. p24 Gag protein ELISA was performed
on all of the lentiviral vector preps using a commercially
available kit (NEN). All lentiviral vectors were produced
and titered at the same time to minimize variability from
batch-to-batch preparations and titering conditions.
β-gal ELISA
MDCK and RAG cells were plated at a density of 5 × 105
cells in 6-well dishes and infected with lentiviral vectors
with [pHRSVcPGKnlsLacZS1.4(+)W(+)] or without the
WPRE [pHRSVcPGKnlsLacZS1.4(+)]. RAG and MDCK
cells were transduced at MOIs of 1 and 3, respectively,
using the titered values from HeLa cells. The media was
replaced 24 hours following the initial infection, and then
the cells were collected 24 hours later. The cells were lysed
using the reagents in the β-gal ELISA kit from Roche (Man-
nheim, Germany). The ELISA was performed as per the
manufacturer's protocol and the plate was scanned using
a Bio-Rad plate reader 680 (Hercules, CA) at 490 nm.
Statistical analysis
The significance of differences between groups at the same
dose of lentivirus was tested by a one-way ANOVA with
the use of StatView 5.0 software (SAS Institute Inc., Cary,
NC). If a probability value of P < 0.05 was obtained, the
Tukey test was used for comparison of each individual
group with the appropriate control groups.
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